e-learning
resources
Paris 2018
Sunday, 16.09.2018
The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Actual treatment practices of pulmonary nontuberculous mycobacteriosis analysed from national insurance claim data in Japan
K. Morimoto (Tokyo, Japan), K. Izumi (Tokyo, Japan), M. Ato (Tokyo, Japan), S. Mitarai (Tokyo, Japan), N. Hasegawa (Tokyo, Japan)
Source:
International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Session:
The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Session type:
Poster Discussion
Number:
347
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Morimoto (Tokyo, Japan), K. Izumi (Tokyo, Japan), M. Ato (Tokyo, Japan), S. Mitarai (Tokyo, Japan), N. Hasegawa (Tokyo, Japan). Actual treatment practices of pulmonary nontuberculous mycobacteriosis analysed from national insurance claim data in Japan. 347
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada
Source: Eur Respir J 2011; 37: 1158-1165
Year: 2011
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Source: Guideline 2020
Year: 2020
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020
Year: 2020
Cross-border management of tuberculosis cases through an updated ERS/WHO TB consilium
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Intrahospital mortality of tuberculosis – our experience of national tuberculosis program implementation
Source: Eur Respir J 2006; 28: Suppl. 50, 129s
Year: 2006
The impact of national recommendations on antibiotic treatment of community acquired pneumonia. Do pediatricians follow the national guidelines?
Source: International Congress 2017 – Pulmonary infection and inflammation
Year: 2017
Effectiveness of TB diagnostics with microbiological methods in TB service and general health care institutions
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011
Trend of delay treatment of patient and healthcare system in diagnosis and management of pulmonary tuberculosis in Iran
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice
Source: Eur Respir J 2016; 48: 1571-1581
Year: 2016
Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat?
Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017
Year: 2017
Lithuanian national tuberculosis manual
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002
The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis
Source: Eur Respir J 2016; 48: 963-971
Year: 2016
Population based survey on the NTM pulmonary disease treatment in Japan
Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Year: 2018
Drug resistance trends and patterns of mycobacterium tuberculosis isolates from pulmonary tuberculosis patients at a tertiary care hospital in Turkey
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
Latent tuberculosis among health care workers in Denmark estimated by IGRA
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Source: Eur Respir J 2011; 38: 516-528
Year: 2011
Protection of healthcare workers against transmission of
Mycobacterium tuberculosis
in hospitals: a review of the evidence
Source: ERJ Open Res, 6 (1) 00317-2019; 10.1183/23120541.00317-2019
Year: 2020
Influence of age, sex and hospitalisation on the administration of tuberculosis medication: an evaluation of routine data from a German health insurer
Source: ERJ Open Res, 6 (3) 00369-2019; 10.1183/23120541.00369-2019
Year: 2020
Schoolchildren from a private school whose teacher had bacillary pulmonary tuberculosis. Case management and control
Source: Eur Respir J 2002; 20: Suppl. 38, 164s
Year: 2002
Predictors of retrospective tuberculosis treatment outcomes in selected health institutions in Nigeria
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept